Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

103802e1-b3a3-4c55-b094-5011798b6de3

afd012e0-8619-5ad5-b77d-bf239b4ce52f

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype

GSVA pathway preview (0 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

No GSVA scores available for this sample.

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

8 twins match this tumor's tissue · 2 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1TCGA-E9-A1N3-01A-12R-A157-07
breast-umap@18
B0.879
2SRR33346942
bladder-landscape@3
0.874
3SRR23303758
bladder-landscape@3
0.862
4BS_09R7GDA7
brain-umap@2
Embryonal tumors0.857
5SRR8943016
bladder-landscape@3
0.856
6MDT-AP-0395
medullo-epn-umap@date-based
MedMedulloblastoma0.852
7SRR8518209
breast-umap@18
C0.850
8MBCProject_0343_T1_RNA
breast-umap@18
B0.846
9TCGA-86-7955-01A-11R-2187-07
lung-landscapes@6
cohortA40.842
10df4e44f9-ee22-43d3-911e-fd4bd826ec0c
colon-landscapes@1
0.842

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 12 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PROTEIN_SECRETION0.400Remibrutinib— uncovered
FATTY_ACID_METABOLISM0.300Inavolisib— uncovered
OXIDATIVE_PHOSPHORYLATION0.300Remibrutinib— uncovered
PEROXISOME0.300Idelalisib— uncovered
BILE_ACID_METABOLISM0.200Inavolisib— uncovered
CHOLESTEROL_HOMEOSTASIS0.200Remibrutinib— uncovered
MYC_TARGETS_V10.200Inavolisib— uncovered
MYC_TARGETS_V20.200Idelalisib— uncovered
SPERMATOGENESIS0.200Inavolisib— uncovered
ADIPOGENESIS0.100Inavolisib— uncovered
HEME_METABOLISM0.100Temsirolimus— uncovered
UNFOLDED_PROTEIN_RESPONSE0.100Idelalisib— uncovered